May 13, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 4, 2024 08:35AM
Apr 4, 2024 08:30AM
Feb 29, 2024 07:30AM
Jan 8, 2024 07:36AM Arbutus Biopharma (ABUS) Announces 2024 Corporate Objectives and Provides Financial Update
Jan 8, 2024 07:30AM
Nov 7, 2023 07:30AM
Nov 7, 2023 07:15AM
Nov 7, 2023 07:15AM
Oct 11, 2023 08:05AM
Sep 11, 2023 04:15PM
Aug 3, 2023 07:30AM Arbutus Reports Second Quarter 2023 Financial Results and Corporate Update
May 4, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM
Feb 28, 2022 09:30AM
Nov 4, 2021 07:30AM
Nov 4, 2021 07:30AM Arbutus Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Aug 5, 2021 07:30AM
Aug 5, 2021 07:30AM
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM
Dec 17, 2020 09:22AM
May 11, 2020 09:28AM Pre-Open Stock Movers 05/11: (MYOK) (AMC) (AVYA) Higher; (VUZI) (UA) (PENN) Lower (more...)
Feb 10, 2020 09:21AM
Aug 5, 2019 07:30AM
Aug 5, 2019 07:30AM
Jul 2, 2019 04:03PM
Jul 2, 2019 04:01PM
Jul 2, 2019 04:01PM
May 6, 2019 04:01PM Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update
May 6, 2019 04:01PM
Mar 7, 2019 04:01PM
Mar 7, 2019 04:01PM
Nov 7, 2018 04:01PM
Nov 7, 2018 04:01PM
Aug 13, 2018 08:33AM
Aug 13, 2018 08:30AM Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO™ (patisiran), for the Treatment of ATTR Amyloidosis
Aug 13, 2018 08:30AM
Aug 2, 2018 04:00PM
Aug 2, 2018 04:00PM
Jul 10, 2018 07:00AM
Jul 10, 2018 07:00AM
Mar 15, 2018 09:27AM
Mar 14, 2018 04:00PM Arbutus Announces Corporate Update and Year-End 2017 Financial Results
Mar 14, 2018 04:00PM

323,579 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All